Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.
0134, did you actually watch the whole of this video? Can't believe that it was too long for you@
Am I right in thinking that these videos are increasing in frequency?
Promising video. Patience needed.....:)
The link between Bitcoin and QBT is based on QBT's pre-commercial potential. Yes, if Bitcoin rises so will QBT. However the real value in QBT will only be seen when hard news comes, when commercial deals are made and QBT's unique contribution to the industry is realised. Until then these movements only benefit the day traders, not the long term holders.
Totally agree Mikey! Trade or wait, do your thing. News will come, no one knows when. In the meantime, nature abhors a vacuum, so this board fills with a lot of pretty meaningless posts! :)
Totally agree. Patience is needed, these changes are irrelevant. Increase in frequency of videos is telling......
Not expecting fireworks yet, though I'm sure it will happen. We must be patient. Hard news is needed now, and we only round the corner from raising 2 mill to take us to commercial deals....
51 million shares traded, and it's only just gone 10am, looking good. Just waiting for news.....
I am confident that the share price will rise to amazing heights. The USP is that its tech benefits other companies hugely, so many will want it. Don't think that the share price will rise much now until proper news, then I'm hoping it will go ballistic! :)
Over 30 million shares bought in first 45 minutes of trading, not bad, I'm holding this one for a good while:)
Signs are looking good. Would love a rise like ARB, and entirely possible. But the similarity will end there, as ARB rise didn't have the same solid foundations. I'm hanging in to my shares, while listening to extremely good top 500 listeners songs on Greatest Hits radio :)
Burstead, you're in work early today
The more I look at this, the better it looks. The NIH have dropped many others on the Activ 2 trial. They unblinded the phase 2 results and decided to continue to phase 3. The Sprinter phase 3 has informed this decision, and ironically actually helped things going forward. Plus the US Is funding it. What's not to like?
Totally agree Leroy. This is not about whether or not it works. It is about understanding what the best parameters are under which it works best. To reassess the trial design like this is good news, as it will get the best out of the drug. Having the US support in this is invaluable
It's a tough journey when dictated by the share price. However, I have followed and been led by the science of this story for 2 years now. SSH is a wonderful communicator of this science, and all the evidence is out there. Trials are not straightforward and this is evidenced by recent news. I remain patient, I really think this will come good.
Spot on Purple1 !
Northscot, I'm not sure you've read my post properly sir! I don't disagree with you.
In the same way that you wouldn't give oral antibiotics if an infection is too mild or too severe, Synairgen's drug needs to be given at the right time in the patient's disease progression for maximum impact. All the work being done is to determine when this is. Although this is quite a share price rollercoaster, this is the nature of drug trials, and all positive in my view. It DOESN'T mean that the drug doesn't work and Synairgen is finished. The science makes sense it's all about applying it properly.
Wpa, you echo my thoughts completely. I've only lost my investment when I sell. Let's be patient. I had a similar investment 20 years ago. It was 8 bagging, then a legal case brought it right back down again. I got my investment out, and then it went back up! Life not changed as a result, but it would have been nice to be mortgage free in my 30s. I may be naiive, but I still have much to believe in and hope for, just with different timelines. GLA
My head says buy 10k shares, cos it must go north from here. My heart just doesn't have the courage to go through with it!